Provention Bio, a Sanofi Company
4 clinical trials · Sponsor
◉ Watch Provention Bio, a Sanofi Company
| Record | Firm | Date |
|---|---|---|
| PRV-3279-2a Trial in Systemic Lupus (NCT05087628) | Provention Bio, a Sanofi Company | 2022-01-20 |
| Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension) (NCT04598893) | Provention Bio, a Sanofi Company | 2020-10-26 |
| PRV-015 in Gluten-free Diet Non-responsive Celiac Disease (NCT04424927) | Provention Bio, a Sanofi Company | 2020-08-24 |
| At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension) (NCT04270942) | Provention Bio, a Sanofi Company | 2020-02-26 |
Track Provention Bio, a Sanofi Company automatically
Every clearance here is in the API, with alerts when new ones post.